Toll-like Receptor (TLR) Inhibitors

TLR3

TLR8

TLR9

TLR2

TLR4

TLR7

TLR1

TLR6

Toll-like Receptor (TLR) Inducers, Ligands, Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	TLR3	TLR8	TLR9	TLR2	TLR4	TLR7	TLR1	TLR6	Purity
Lipopolysaccharides, from E. coli O55:B5					TLR4
Resiquimod		TLR8				TLR7			99.95%
Resatorvid					TLR4				99.95%
Pam2Cys				TLR2
Imiquimod						TLR7			99.96%
C29				TLR2					≥98.0%
Pam3CSK4 TFA				TLR2			TLR1		99.66%
Hydroxychloroquine sulfate			TLR9			TLR7			99.99%
Agatolimod sodium			TLR9						99.13%
Polyinosinic-polycytidylic acid sodium	TLR3								99.40%
ODN 1826 sodium			TLR9						99.51%
CU-CPT 4a	TLR3, IC₅₀: 3.44 μM (in RAW 264.7 cells)								99.34%
Enpatoran		TLR8, IC₅₀: 24.1 nM (in HEK293 cells) TLR8, IC₅₀: 620 nM (in peripheral blood mononuclear cells (PBMCs)) TLR8, IC₅₀: 120 nM ( in whole blood (WB) cells)				TLR7, IC₅₀: 11.1 nM (in HEK293 cells) TLR7, IC₅₀: 68.3 nM (in peripheral blood mononuclear cells (PBMCs)) TLR7, IC₅₀: 2.2 nM ( in whole blood (WB) cells)			99.80%
ODN 1826			TLR9						99.69%
Diprovocim				TLR2			TLR1		98.82%
CU-CPT22				TLR2			TLR1		≥99.0%
Imiquimod hydrochloride						TLR7			99.77%
TLR4-IN-C34					TLR4				99.90%
Agatolimod			TLR9						98.49%
Thiamine hydrochloride					TLR4				99.97%
Motolimod		TLR8							98.12%
Telratolimod		TLR8				TLR7			98.85%
Atractylenolide I			TLR9			TLR7			99.94%
Vesatolimod						TLR7			99.90%
Physcion					TLR4				99.00%
AT791			TLR9, IC₅₀: 0.04 μM			TLR7, IC₅₀: 3.33 μM			98.77%
Schaftoside					TLR4				99.57%
CU-T12-9				TLR2, EC₅₀: 52.9 nM (in HEK-Blue cells)			TLR1, EC₅₀: 52.9 nM (in HEK-Blue cells)		99.96%
MMG-11				TLR2					99.24%
ODN 1668 sodium			TLR9						98.79%
Enpatoran hydrochloride		TLR8, IC₅₀: 24.1 nM				TLR7, IC₅₀: 11.1 nM			99.42%
ODN 2395			TLR9						98.39%
Sparstolonin B				TLR2	TLR4				99.94%
Selgantolimod		TLR8							98.18%
ODN 1018			TLR9						99.28%
ODN 2216			TLR9
ODN 2395 sodium			TLR9						98.20%
CL097		TLR8				TLR7			99.90%
RS 09					TLR4				99.88%
Neoseptin 3					TLR4, EC₅₀: 18.5 μM				99.21%
D-Glucuronic acid					TLR4				≥98.0%
TLR9-IN-1			human TLR9, IC₅₀: 7 nM						99.67%
FSL-1 TFA				TLR2				TLR6	99.65%
Okanin					TLR4				99.98%
Teneligliptin hydrobromide hydrate					TLR4				99.97%
RS 09 TFA					TLR4				99.87%
Gardiquimod		TLR8				TLR7			99.91%
Robinin				TLR2	TLR4				99.09%
TLR7/8-IN-1		TLR8				TLR7			99.92%
ssRNA40 sodium		TLR8				TLR7
TLR7/8 agonist 1		TLR8				TLR7			98.42%
CL075		TLR8							99.18%
E6446 dihydrochloride			TLR9			TLR7			99.96%
IAXO-102					TLR4				≥98.0%
ODN 1668			TLR9						98.79%
Isofraxidin					TLR4				99.94%
TL8-506		TLR8, EC₅₀: 30 nM
Monophosphoryl lipid A					TLR4				≥99.0%
TLR7/8 agonist 1 dihydrochloride		TLR8				TLR7			99.70%
CU-CPT-9a		TLR8, IC₅₀: 0.5 nM							99.74%
NecroX-7					TLR4				99.69%
Dracorhodin perchlorate					TLR4				99.14%
E6446			TLR9			TLR7			98.78%
Loxoribine						TLR7			99.66%
AN-3485	TLR3			TLR2	TLR4
MD2-IN-1					TLR4				99.88%
DSR-6434						TLR7, EC₅₀: 7.2 nM (Human) TLR7, EC₅₀: 4.6 nM (Mice)			99.32%
Procyanidin B3					TLR4				99.92%
CAY10614					TLR4, IC₅₀: 1.675 μM (in HEK293 cells)				98.87%
CpG ODN 10101			TLR9						99.44%
CU-CPT-8m		TLR8, IC₅₀: 67 nM							99.98%
Kaempferol 3-O-sophoroside				TLR2	TLR4				99.41%
Gardiquimod diTFA		TLR8				TLR7			≥99.0%
L6H21					TLR4				99.19%
ODN M362			TLR9
ODN 20844			TLR9			TLR7
Ecliptasaponin A					TLR4				99.50%
L48H37					TLR4
CU-CPT17e	TLR3	TLR8	TLR9						99.00%
TLR7/8 agonist 3		TLR8				TLR7			99.96%
Chloranil					TLR4				98%
Magnesium citrate					TLR4				≥98.0%
C12-TLRa		TLR8				TLR7			≥99.0%
MD2-TLR4-IN-1					TLR4				98.16%
CL264						TLR7			98.63%
AXC-715 trihydrochloride		TLR8, EC₅₀: 1.6 μM				human TLR7, EC₅₀: 0.643 μM			99.76%
Phellopterin					TLR4				99.94%
Imiquimod maleate						TLR7			99.25%
GSK2245035						TLR7			99.85%
RKH acetate					TLR4				99.45%
CU-115		TLR8, IC₅₀: 1.04 μM				TLR7, IC₅₀: 50 μM			99.63%
Astringin					TLR4				99.54%
TLR7 agonist 3						TLR7			99.90%
CU-CPT9b		TLR8, IC₅₀: 0.7 nM TLR8, Kd: 21 nM							99.03%
Hydroxychloroquine sulfate (Standard)			TLR9			TLR7
Resiquimod (GMP)		TLR8				TLR7
MAPK-IN-1					TLR4
AZD8848						TLR7			99.14%
Polygalasaponin F					TLR4				99.85%
CL097 hydrochloride		TLR8				TLR7			99.90%
SM-324405						human TLR7, pEC₅₀: 7.3 Rat TLR7, pEC₅₀: 6.6 TLR7, EC₅₀: 50 nM			98.52%
PF-4878691						TLR7			99.89%
BBIQ						TLR7, EC₅₀: 59.1 nM (Human TLR7)			99.85%
ORN 06 sodium						TLR7
1V209						TLR7			99.67%
Fosfenopril					TLR4				99.85%
E104						TLR7			98.02%
TLR7 agonist 1						TLR7, IC₅₀: 90 nM			98.19%
LHC-165						TLR7			≥98.0%
FAM-labeled ODN 1826 sodium			TLR9						98.03%
MMG-11 quarterhydrate				TLR2					98.70%
TLR7 agonist 6						TLR7, EC₅₀: ~4 nM			98.08%
TLR7/8 agonist 4		TLR8				TLR7			99.04%
SMU-L11						TLR7, EC₅₀: 0.024 μM			99.64%
PVP-037.2		TLR8				TLR7			99.18%
Kdo2-Lipid A ammonium					TLR4				99.00%
Resiquimod-d₅		TLR8				TLR7			99.84%
SM-276001						TLR7			99.41%
AXC-715 hydrochloride		TLR8, EC₅₀: 1.6 μM				TLR7, EC₅₀: 0.643 μM			99.46%
TMX-201						TLR7
Toll-like receptor modulator		TLR8				TLR7			99.36%
Tomentosin				TLR2	TLR4				98.95%
MTvkPABC-P5 TFA						TLR7			98.78%
ODN M326 sodium			TLR9
MC-Val-Cit-PAB-Amide-TLR7 agonist 4		TLR8				TLR7			99.39%
TLR7 agonist 4						TLR7, EC₅₀: 4.3 nM			98.87%
TLR7/8 agonist 8		TLR8, EC₅₀: 12 nM				TLR7, EC₅₀: 27 nM			98.69%
ODN 24987			TLR9
FSL-1				TLR2				TLR6
Diprovocim-X				TLR2			TLR1		98.64%
Pam3CSK4				TLR2			TLR1
TLR7 agonist 20 hydrochloride		TLR8, EC₅₀: 17.21 μM				TLR7, EC₅₀: 0.23 μM			99.86%
TLR4-IN-C34-C2-amide-C6-OH					TLR4				99.62%
TLR4/NF-κB-IN-1					TLR4				99.92%
ODN 24888			TLR9			TLR7
(S)-Hydroxychloroquine			TLR9			TLR7
(R)-Hydroxychloroquine			TLR9			TLR7
Guretolimod						TLR7
TLR7/8 agonist 4 TFA		TLR8				TLR7
TLR8 agonist 2 hydrochloride		TLR8, EC₅₀: 3 nM				TLR7, EC₅₀: 33.33 μM
TLR8 agonist 2		TLR8, EC₅₀: 3 nM				TLR7, EC₅₀: 33.33 μM
UC-1V150						TLR7
TLR7-IN-1						TLR7, IC₅₀: 0.001 μM
WYJ-2				TLR2
TLR7 agonist 27						TLR7, EC₅₀: 238.1 nM
TL8-506 (GMP)		TLR8, EC₅₀: 30 nM
TLR7 agonist 28						TLR7
TLR2 agonist 1				hTLR2, EC₅₀: 116 pM
Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH					TLR4
TLR7 agonist 24						TLR7, EC₅₀: 3.72 μM
SjDX5-271					TLR4
KBD4466		TLR8, IC₅₀: 2.8 nM				TLR7, IC₅₀: 0.9 nM
TLR7 agonist 14						TLR7, IC₅₀: 18 nM
Cholesterol oxidase, rhodococcus sp				TLR2
TLR7 agonist 21		TLR8, EC₅₀: 5932 nM				human TLR7, EC₅₀: 17.53 nM mTLR7, EC₅₀: 41.7 nM
TLR7 agonist 7						TLR7, EC₅₀: ~4 nM
3M-011		TLR8				TLR7
TLR8 agonist 8		TLR8
TLR7 agonist 20		TLR8, EC₅₀: 17.21 μM				TLR7, EC₅₀: 0.23 μM
TLR7 agonist 29						human TLR7, EC₅₀: 5.2 nM mTLR7, EC₅₀: 48.2 nM
ODN M326			TLR9
TLR7 agonist 26						TLR7, EC₅₀: 225.5 nM
TLR7 agonist 8						TLR7, EC₅₀: ~4 nM
CCL-34					TLR4
ORN 06						TLR7
TLR8 agonist 7		TLR8
NF-κB-IN-14					TLR4
SjDX5-53				TLR2
Rabeximod				TLR2	TLR4
TLR7 agonist 9						TLR7
TLR8 agonist 9		TLR8
Xanthine oxidase-IN-6					TLR4
Vidutolimod			TLR9
BI1543673		TLR8			TLR4	TLR7
Mumefural					TLR4
GlcNAc-MurNAc					TLR4, Kd: 383 μM
Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH					TLR4
TLR7 agonist 17						human TLR7, EC₅₀: 12 nM mTLR7, EC₅₀: 17 nM
Polyinosinic-polycytidylic acid potassium	TLR3
TLR7/8 agonist 11		TLR8, EC₅₀: 13.1 nM				human TLR7, EC₅₀: 31.1 nM
P53/TLR2 modulator-1				TLR2
Pam3CSK4-Biotin				TLR2			TLR1
M199	TLR3		TLR9						98.55%
MTT5						TLR7
ORN 02 sodium		TLR8
TLR4L 10					TLR4
ORN 02		TLR8
Macrophage-activating lipopeptide 2				TLR2				TLR6
TLR7 agonist 5						TLR7, EC₅₀: ~4 nM
AYK004		TLR8				TLR7
AYK004-B1						TLR7, EC₅₀: 0.2265 nM
Isatoribine						TLR7
UM-3006		TLR8				TLR7
BBIQ (GMP)						human TLR7, EC₅₀: 59.1 nM
Creatine ethyl ester	TLR3			TLR2	TLR4	TLR7

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4